ACAD logo

ACADIA Pharmaceuticals (ACAD) Net Income

Annual Net Income

-$61.29 M
+$154.69 M+71.62%

December 31, 2023


Summary


Performance

ACAD Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADprofitabilitymetrics:

Quarterly Net Income

$32.77 M
-$624.00 K-1.87%

September 30, 2024


Summary


Performance

ACAD Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADprofitabilitymetrics:

TTM Net Income

$128.51 M
+$97.94 M+320.44%

September 30, 2024


Summary


Performance

ACAD TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ACAD Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.6%+150.3%+186.4%
3 y3 years+78.2%+326.6%+167.1%
5 y5 years+75.0%+178.1%+154.6%

ACAD Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+71.6%-28.5%+129.0%at high+159.1%
5 y5-yearat high+78.2%-28.5%+129.0%at high+145.6%
alltimeall time-504.8%+78.8%-28.5%+129.0%at high+141.5%

ACADIA Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
$32.77 M(-1.9%)
$128.51 M(+320.4%)
Jun 2024
-
$33.39 M(+101.7%)
$30.57 M(-1887.4%)
Mar 2024
-
$16.55 M(-63.9%)
-$1.71 M(-97.2%)
Dec 2023
-$61.29 M(-71.6%)
$45.80 M(-170.3%)
-$61.29 M(-58.8%)
Sep 2023
-
-$65.18 M(-5950.6%)
-$148.81 M(+34.3%)
Jun 2023
-
$1.11 M(-102.6%)
-$110.81 M(-24.1%)
Mar 2023
-
-$43.02 M(+3.1%)
-$145.94 M(-32.4%)
Dec 2022
-$215.97 M(+28.7%)
-$41.73 M(+53.5%)
-$215.97 M(-0.6%)
Sep 2022
-
-$27.18 M(-20.1%)
-$217.34 M(+6.2%)
Jun 2022
-
-$34.01 M(-69.9%)
-$204.62 M(-4.6%)
Mar 2022
-
-$113.06 M(+162.3%)
-$214.48 M(+27.8%)
Dec 2021
-$167.87 M(-40.4%)
-$43.09 M(+198.1%)
-$167.87 M(-12.4%)
Sep 2021
-
-$14.46 M(-67.0%)
-$191.54 M(-26.8%)
Jun 2021
-
-$43.87 M(-34.0%)
-$261.74 M(+0.7%)
Mar 2021
-
-$66.45 M(-0.5%)
-$260.01 M(-7.7%)
Dec 2020
-$281.58 M(+19.7%)
-$66.76 M(-21.1%)
-$281.58 M(+5.1%)
Sep 2020
-
-$84.66 M(+100.9%)
-$267.86 M(+19.0%)
Jun 2020
-
-$42.14 M(-52.1%)
-$225.18 M(-5.4%)
Mar 2020
-
-$88.02 M(+66.0%)
-$237.98 M(+1.2%)
Dec 2019
-$235.26 M(-4.1%)
-$53.04 M(+26.3%)
-$235.26 M(-5.0%)
Sep 2019
-
-$41.98 M(-23.6%)
-$247.72 M(-7.5%)
Jun 2019
-
-$54.94 M(-35.6%)
-$267.88 M(-3.0%)
Mar 2019
-
-$85.30 M(+30.3%)
-$276.20 M(+12.6%)
Dec 2018
-$245.19 M(-15.3%)
-$65.49 M(+5.4%)
-$245.19 M(-1.4%)
Sep 2018
-
-$62.14 M(-1.8%)
-$248.57 M(-1.2%)
Jun 2018
-
-$63.27 M(+16.5%)
-$251.68 M(-1.6%)
Mar 2018
-
-$54.30 M(-21.2%)
-$255.86 M(-11.6%)
Dec 2017
-$289.40 M(+6.6%)
-$68.87 M(+5.6%)
-$289.40 M(-3.3%)
Sep 2017
-
-$65.25 M(-3.3%)
-$299.23 M(-2.1%)
Jun 2017
-
-$67.44 M(-23.2%)
-$305.59 M(-1.3%)
Mar 2017
-
-$87.84 M(+11.6%)
-$309.47 M(+14.0%)
Dec 2016
-$271.39 M(+65.0%)
-$78.70 M(+9.9%)
-$271.39 M(+13.8%)
Sep 2016
-
-$71.61 M(+0.4%)
-$238.48 M(+15.9%)
Jun 2016
-
-$71.32 M(+43.3%)
-$205.77 M(+18.4%)
Mar 2016
-
-$49.76 M(+8.7%)
-$173.83 M(+5.7%)
Dec 2015
-$164.44 M(+77.8%)
-$45.78 M(+17.7%)
-$164.44 M(+11.8%)
Sep 2015
-
-$38.91 M(-1.2%)
-$147.03 M(+10.6%)
Jun 2015
-
-$39.38 M(-2.5%)
-$132.91 M(+15.5%)
Mar 2015
-
-$40.38 M(+42.3%)
-$115.02 M(+24.4%)
Dec 2014
-$92.47 M(+143.7%)
-$28.37 M(+14.4%)
-$92.47 M(+21.4%)
Sep 2014
-
-$24.79 M(+15.3%)
-$76.16 M(+22.7%)
Jun 2014
-
-$21.50 M(+20.6%)
-$62.07 M(+25.0%)
Mar 2014
-
-$17.83 M(+48.0%)
-$49.65 M(+30.8%)
Dec 2013
-$37.95 M
-$12.05 M(+12.7%)
-$37.95 M(+16.0%)
Sep 2013
-
-$10.70 M(+17.8%)
-$32.71 M(+34.0%)
DateAnnualQuarterlyTTM
Jun 2013
-
-$9.08 M(+48.3%)
-$24.42 M(+17.6%)
Mar 2013
-
-$6.12 M(-10.1%)
-$20.75 M(-0.5%)
Dec 2012
-$20.85 M(-8.4%)
-$6.81 M(+183.5%)
-$20.85 M(+7.8%)
Sep 2012
-
-$2.40 M(-55.7%)
-$19.34 M(-12.1%)
Jun 2012
-
-$5.42 M(-12.8%)
-$22.01 M(-4.9%)
Mar 2012
-
-$6.22 M(+17.3%)
-$23.15 M(+1.7%)
Dec 2011
-$22.77 M(-250.4%)
-$5.30 M(+4.4%)
-$22.77 M(-295.0%)
Sep 2011
-
-$5.08 M(-22.6%)
$11.68 M(-6.8%)
Jun 2011
-
-$6.56 M(+12.4%)
$12.53 M(-15.3%)
Mar 2011
-
-$5.83 M(-120.0%)
$14.79 M(-2.3%)
Dec 2010
$15.14 M(-133.5%)
$29.14 M(-789.4%)
$15.14 M(-166.7%)
Sep 2010
-
-$4.23 M(-1.4%)
-$22.69 M(-16.6%)
Jun 2010
-
-$4.29 M(-21.9%)
-$27.19 M(-23.7%)
Mar 2010
-
-$5.49 M(-36.9%)
-$35.63 M(-21.1%)
Dec 2009
-$45.15 M(-29.7%)
-$8.69 M(-0.4%)
-$45.15 M(-10.5%)
Sep 2009
-
-$8.73 M(-31.4%)
-$50.42 M(-12.0%)
Jun 2009
-
-$12.73 M(-15.2%)
-$57.31 M(-8.8%)
Mar 2009
-
-$15.00 M(+7.4%)
-$62.87 M(-2.1%)
Dec 2008
-$64.24 M(+13.9%)
-$13.96 M(-10.6%)
-$64.24 M(-4.6%)
Sep 2008
-
-$15.61 M(-14.6%)
-$67.32 M(-0.6%)
Jun 2008
-
-$18.29 M(+11.6%)
-$67.75 M(+12.5%)
Mar 2008
-
-$16.38 M(-3.9%)
-$60.22 M(+6.8%)
Dec 2007
-$56.39 M(+25.2%)
-$17.04 M(+6.2%)
-$56.39 M(+8.9%)
Sep 2007
-
-$16.05 M(+49.2%)
-$51.80 M(+10.2%)
Jun 2007
-
-$10.75 M(-14.3%)
-$47.02 M(-2.3%)
Mar 2007
-
-$12.55 M(+0.8%)
-$48.13 M(+6.9%)
Dec 2006
-$45.05 M(+32.0%)
-$12.45 M(+10.5%)
-$45.05 M(+5.3%)
Sep 2006
-
-$11.26 M(-5.1%)
-$42.80 M(-2.4%)
Jun 2006
-
-$11.87 M(+25.4%)
-$43.84 M(+15.3%)
Mar 2006
-
-$9.47 M(-7.2%)
-$38.01 M(+11.4%)
Dec 2005
-$34.13 M(+31.7%)
-$10.20 M(-17.1%)
-$34.14 M(+9.2%)
Sep 2005
-
-$12.31 M(+103.8%)
-$31.27 M(+24.2%)
Jun 2005
-
-$6.04 M(+8.0%)
-$25.18 M(+0.6%)
Mar 2005
-
-$5.59 M(-23.8%)
-$25.02 M(-3.4%)
Dec 2004
-$25.92 M(+83.9%)
-$7.33 M(+18.0%)
-$25.92 M(+17.2%)
Sep 2004
-
-$6.21 M(+5.6%)
-$22.11 M(+13.9%)
Jun 2004
-
-$5.89 M(-9.2%)
-$19.41 M(+17.6%)
Mar 2004
-
-$6.48 M(+84.0%)
-$16.50 M(+22.9%)
Dec 2003
-$14.09 M(+9.5%)
-$3.52 M(0.0%)
-$13.43 M(+35.6%)
Sep 2003
-
-$3.52 M(+18.4%)
-$9.91 M(+55.2%)
Jun 2003
-
-$2.98 M(-12.7%)
-$6.39 M(+87.3%)
Mar 2003
-
-$3.41 M
-$3.41 M
Dec 2002
-$12.87 M(-10.7%)
-
-
Dec 2001
-$14.41 M(+41.3%)
-
-
Dec 2000
-$10.19 M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual net profit?
  • What is the all time high annual net income for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual net income year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly net income year-on-year change?
  • What is ACADIA Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM net income year-on-year change?

What is ACADIA Pharmaceuticals annual net profit?

The current annual net income of ACAD is -$61.29 M

What is the all time high annual net income for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual net profit is $15.14 M

What is ACADIA Pharmaceuticals annual net income year-on-year change?

Over the past year, ACAD annual net profit has changed by +$154.69 M (+71.62%)

What is ACADIA Pharmaceuticals quarterly net profit?

The current quarterly net income of ACAD is $32.77 M

What is the all time high quarterly net income for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly net profit is $45.80 M

What is ACADIA Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ACAD quarterly net profit has changed by +$97.94 M (+150.27%)

What is ACADIA Pharmaceuticals TTM net profit?

The current TTM net income of ACAD is $128.51 M

What is the all time high TTM net income for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM net profit is $128.51 M

What is ACADIA Pharmaceuticals TTM net income year-on-year change?

Over the past year, ACAD TTM net profit has changed by +$277.31 M (+186.36%)